User login
One practice’s success with platelet-rich plasma therapy
How best to prevent acute pain from becoming chronic?
JOURNAL SCANSummary of Key ArticlesExploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
JOURNAL SCAN Summary of Key ArticlesExploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
A supplement to Family Practice News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Family Practice News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Family Practice News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
JOURNAL SCANSummary of Key ArticlesExploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
A supplement to Clinical Endocrinology News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Clinical Endocrinology News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
A supplement to Clinical Endocrinology News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
Topics
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Knowing your patients’ cancer family history saves lives
Best Practices in IVF Nursing: Fertility preservation: Technological advances make future children possible for women undergoing cancer treatment today
The American Cancer Society estimates that, in the United States, 1,660,290 people will be diagnosed with cancer during 2013.1 About 8.9% of them, or nearly 148,000 people, will be under the age of 45, according to incidence data from the National Cancer Institute.2 We are familiar with the complex constellation of emotions – arguably even more profound when the patient is in the prime of his or her life – that surround a cancer diagnosis. Fortunately, significant advances in early diagnosis and in the efficacy of cancer therapies have led to improved long-term survival for many of these patients.
In the past, the sole focus was on preserving and prolonging life. Today, the need to address fertility concerns and other quality of life issues is recognized from the start.
The American Cancer Society estimates that, in the United States, 1,660,290 people will be diagnosed with cancer during 2013.1 About 8.9% of them, or nearly 148,000 people, will be under the age of 45, according to incidence data from the National Cancer Institute.2 We are familiar with the complex constellation of emotions – arguably even more profound when the patient is in the prime of his or her life – that surround a cancer diagnosis. Fortunately, significant advances in early diagnosis and in the efficacy of cancer therapies have led to improved long-term survival for many of these patients.
In the past, the sole focus was on preserving and prolonging life. Today, the need to address fertility concerns and other quality of life issues is recognized from the start.
The American Cancer Society estimates that, in the United States, 1,660,290 people will be diagnosed with cancer during 2013.1 About 8.9% of them, or nearly 148,000 people, will be under the age of 45, according to incidence data from the National Cancer Institute.2 We are familiar with the complex constellation of emotions – arguably even more profound when the patient is in the prime of his or her life – that surround a cancer diagnosis. Fortunately, significant advances in early diagnosis and in the efficacy of cancer therapies have led to improved long-term survival for many of these patients.
In the past, the sole focus was on preserving and prolonging life. Today, the need to address fertility concerns and other quality of life issues is recognized from the start.
BEST PRACTICES IN: Thermal Integrity of Shipping Containers Used by Private Cord Blood Banks
A supplement to Ob.Gyn. News. This supplement was sponsored by CORD:USE Cord Blood Bank, Inc.
• Introduction
• Materials and methods
• Results
• Discussion
Faculty/Faculty Disclosure
Robert N. Wolfson, MD, PhD, FACOG, FAIUM
Specialists in Women’s Health, LLC
Colorado Springs, Colorado
Dr Wolfson has nothing to disclose.
Copyright ©2013 by Frontline Medical Communications Inc.
A supplement to Ob.Gyn. News. This supplement was sponsored by CORD:USE Cord Blood Bank, Inc.
• Introduction
• Materials and methods
• Results
• Discussion
Faculty/Faculty Disclosure
Robert N. Wolfson, MD, PhD, FACOG, FAIUM
Specialists in Women’s Health, LLC
Colorado Springs, Colorado
Dr Wolfson has nothing to disclose.
Copyright ©2013 by Frontline Medical Communications Inc.
A supplement to Ob.Gyn. News. This supplement was sponsored by CORD:USE Cord Blood Bank, Inc.
• Introduction
• Materials and methods
• Results
• Discussion
Faculty/Faculty Disclosure
Robert N. Wolfson, MD, PhD, FACOG, FAIUM
Specialists in Women’s Health, LLC
Colorado Springs, Colorado
Dr Wolfson has nothing to disclose.
Copyright ©2013 by Frontline Medical Communications Inc.
Clinical Utility of Low-Density Lipoprotein Particles and Apolipoprotein B in Patients with Cardiovascular Risk
